March 31, 2020

Automated Endoscope Reprocessors (AER) Market Is Expected To Reach US$ 554.4 Mn By 2026

The latest market report published by Credence Research, Inc. “Automated Endoscope Reprocessors Market – Growth, Future Prospects, and Competitive Analysis, 2018 – 2026” the global market for automated endoscope reprocessors was valued at US$ 364.2 million in 2017 and is expected to reach US$ 554.4 million by 2026 for a CAGR of 4.8 percent between 2018 and 2026.

Market Insights

The global automated endoscope reprocessors (AER) market unveils productive growth during the forecast period from 2018 to 2026, attributed to high-end technical progresses in automation protocols in the endoscope reprocessing machines coupled with faster turnaround time to optimize accurate results with zero contamination factor. Technology assessments in automated endoscope reprocessors such as portable / bench top and stand-alone devices are gaining momentum in hospitals and clinics. Automated endoscope reprocessing machines have improved capabilities compared to basic or simple machines or manual cleaning of complex, digital, micro-processing machines with enhanced capabilities and features such as faster reprocessing cycle time (approx. 30 minutes), temperature control mechanism, barcode scanner, asynchronous operation, alcohol flush, automated leak test, etc.

Browse Full Report Originally Published by Credence Research at

In the recent period, the passage through automated endoscope reprocessors has gained a higher momentum. ADVANTAGE PLUS automated endoscope reprocessor manufactured by Medivators physically isolates perfect and unclean reprocessing regions to minimize the risk of error and cross-contamination and therefore ensures higher patient safety by monitoring each endoscope channel separately for blocking and flow protection of complete high-level disinfection.

However, problems arise in a few instances during complete washing and drying; also contamination associated with the use of endoscopes, i.e. a high risk of infections associated with improper sterilization of endoscopes, may hinder market growth during the forecast period. Moreover, the choice of physicians to manually clean endoscopes in developing regions in Asia-Pacific, Latin America and the Middle East and Africa (MEA) regions may show slow growth in adoption. High prices of AER machines are also a very important factor, which restricts the overall consumption of AER machines in hospitals and outpatient centers in developing economies.

Furthermore, rising endoscopy procedures, minimally invasive surgeries, infection control awareness, rising purchasing power of healthcare facilities, beneficiary schemes for reimbursement, and higher utilization of advanced automated machines in the developing nations such as India, China, Brazil, Mexico, South Africa and others are various external factors fueling the demand for automated endoscope reprocessors in near future.

Key Market Movements:

  • Globally, the automated endoscope reprocessors market remains to exhibit a profitable growth with a CAGR of 4.8% for the period from 2018 to 2026
  • Based on the product, the dual basin AER segment expected to spearhead the market with increasing applications in endoscopy procedures.
  • Top AER FDA approved machines also utilize updated high-level disinfection (HLD) or liquid chemical sterilization validation testing with duodenoscopes, gaining more traction in terms of revenue generation during the forecast period
  • North America to contribute maximum revenue share in the overall growth of the automated endoscope reprocessors market, attributed to rising endoscopy procedures, higher adoption of top end models in more than 75 percent of the hospitals, increasing awareness and programs held by major service providers, maximum reimbursement coverage, higher patient safety and the presence of key manufacturers & sophisticated healthcare infrastructure in the U.S. and Canada
  • Eastern Europe, Latin America, and Asia Pacific to show promising opportunities and a healthy CAGR during the forecast period. Rising awareness among the individuals about the concerns for infectious diseases and its treatment (mainly GI – gastrointestinal endoscopy procedures), surging geriatric population & a number of healthcare settings, and increasing healthcare spending in India, China, and Japan are attributed to the market growth.
  • Major players in this vertical are MEDIVATORS Inc., Advanced Sterilization Products (A Johnson & Johnson Company), Arc Healthcare Solutions, Bes Decon (A Division of Bes Rehab Ltd), Cantel Medical, Custom Ultrasonics, Endo-Technik W. Griesat, Getinge, Laboratories Anios (A Subsidiary of Ecolab Inc.), Metrex Research, Olympus, Steelco, Steris, Wassenburg Medical (A Member of Hoya) and others.

Access Free Sample Copy of Research Report:

[Note: Our Free Complimentary Sample Report Accommodate a Brief Introduction To The Synopsis, TOC, List of Tables and Figures, Competitive Landscape and Geographic Segmentation, Innovation and Future Developments Based on Research Methodology are also Included]

Report Scope by Segments

By Product Segment

  • Single Basin Automated Endoscope Reprocessors
  • Double Basin Automated Endoscope Reprocessors

By Modality Segment

  • Standalone Automated Endoscope Reprocessors
  • Portable/Bench Top Automated Endoscope Reprocessors

By End-user Segment

  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers

By Geography Segment

  • North America (the U.S., Rest of North America)
  • Europe (U.K., Germany, France, Rest of Europe)
  • Asia Pacific (China, Japan, India, Rest of Asia Pacific)
  • Rest of World (Middle East & Africa (MEA), Latin America)

Access Free Sample Copy of Research Report:

Leave a Reply

Your email address will not be published. Required fields are marked *